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Abstract: Estimation of ventricular contractility is clinically important in diagnosing cardiac dysfunction 
in the critically ill. However, experimental assessment of indexes of ventricular contractility,  such as the 
end-systolic pressure-volume relationship requires a highly invasive maneuver. This research describes 
the use of a previously validated cardiovascular system (CVS) model and identification process to 
evaluate the right-ventricle contractility as well as the right ventricular arterial coupling in septic shock. 
The results show good agreement with the gold-standard experimental assessment (conductance catheter 
method), and offer the potential to develop a model-based sensor to monitor the coupling in clinical real-
time. 
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1. INTRODUCTION 
When trying to assess ventricular systolic function, the 
estimation of ventricular contractility is known to be one of 
the key steps. Determination of ventricular function and 
contractility are clinically important in assessing and 
diagnosing cardiac and circulation dysfunction in critically ill 
patients. In particular, the differential diagnosis of septic 
shock, different from other causes of reduced cardiac output, 
is time critical and plays a major role in therapeutic decision 
making. Hence, such assessments can play a crucial role in 
the management of the critically ill. 
Experimentally, the conductance catheter method allows for 
the determination of indexes of ventricular contractility, such 
as the end-systolic pressure-volume relationship (ESPVR). 
This method requires the recording of several pressure-
volume loops during an induced preload reduction (caval 
occlusion), which is a highly invasive maneuver that disturbs 
the circulation further and would not be readily performed at 
the bedside for diagnostic purposes. It is easily seen that this 
procedure raises significant ethical and medical concerns.  
Attempts to bypass the preload reduction have been 
suggested, such as "single-beat" methods (Brimioulle et al., 
2003), to avoid this potential risk. However, these studies are 
not completely reliable as they failed to detect the (known) 
contractility modifications induced by pharmacologic 
interventions (Lambermont et al., 2004).  
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Hence, an accurate replacement measure that is not further 
invasive would have clinically significant value. 
Recently, mathematical models of the cardiovascular system 
(CVS) have been developed to assist medical professionals in 
differentiating and diagnosing CVS disturbances, such as 
pulmonary embolism, changes in positive end expiratory 
pressure (PEEP) or septic shock (Desaive et al., 2008, 
Starfinger et al., 2008b, Starfinger et al., 2008d, Starfinger et 
al., 2008c, Starfinger et al., 2007). These CVS models were 
able to capture all the fundamental CVS pressure and volume 
values and trends when compared to measured experimental 
data. The goal is to use the models and readily available 
clinical measurements to enable non-invasive patient specific 
monitoring and diagnosis.  
The specific aim of this study is to use this previously 
described CVS model and identification process (Desaive et 
al., 2008, Starfinger et al., 2008b, Starfinger et al., 2008d, 
Starfinger et al., 2008c) to estimate the right ventricular 
contractility and the right ventricular-arterial coupling. 
Animal model data is used from a previously published 
porcine experiment of induced septic shock combined with 
continuous veno-venous hemofiltration (CVVH) therapy, 
which thus includes both septic shock and therapeutic 
dynamics (Lambermont et al., 2006). Hence, this article 
compares a gold-standard clinical assessment (conductance 
catheter method) to a non-invasive model-based method. 
This model-based approach offers a potentially reliable 
procedure to assess the right ventricle (RV) contractility, as 
well as the right ventricular-arterial coupling. This method 
thus opens up a new way to estimate the right ventricle 
systolic function in humans due to its preload independence. 
 
 
     
 
Equally importantly, it offers the potential to develop a 
model-based sensor to monitor this metric in clinical real-
time and thus use it in determining therapy, using only 
readily available clinical data. 
 
2. MATERIALS AND METHODS 
All experimental procedures and protocols used in this 
investigation were reviewed and approved by the Ethics 
Committee of the Medical Faculty of the University of Liege. 
They were performed in accordance with the Guide for the 
Care and Use of Laboratory Animals as adopted and 
promulgated by the U.S. National Institutes of Health (NIH 
Publication No.85-23, revised 1996). The surgical 
preparation and experimental protocol are described in 
(Lambermont et al., 2006) with relevant details repeated here. 
2.1 Experimental protocol and physiological measurements 
Experiments were performed on 6 healthy pure pietran pigs 
of either sex weighing from 20 to 30kg. The animals were 
premedicated and anesthetized as described previously 
(Lambermont et al., 2006). A micromanometer-tipped 
catheter (Sentron pressure-measuring catheter, Cordis, 
Miami, FL, U.S.A.) was inserted into the main pulmonary 
artery and a 14-mm diameter perivascular flow probe 
(Transonic Systems, Ithaca, NY, U.S.A.) was adjusted 
around the main pulmonary artery 2 cm downstream of the 
pulmonary valve. Left atrial pressure was measured with a 
micromanometer-tipped catheter and systemic blood pressure 
was monitored with a micromanometer-tipped catheter 
inserted into the descending thoracic aorta through the left 
femoral artery. A 7F, 12-electrode (8-mm interelectrode 
distance) conductance micromanometer-tipped catheter (CD 
Leycom, Zoetermeer, The Netherlands) was inserted through 
the RV infundibulum into the right ventricle and positioned 
so that all electrodes were in the RV cavity. A 6F Fogarty 
balloon catheter (Baxter Healthcare Corp., Oakland, Calif) 
was advanced into the inferior vena cava through a right 
femoral venotomy. Inflation of this balloon produced gradual 
preload reduction. 
After a 30 min stabilization period, the animals received a 
0.5mg/kg endotoxin infusion (Lipopolysaccharide from 
Escherichia Coli serotype 0127:B8; Sigma Chemical, St 
Louis, MO, USA) over a 30 min period (from T0 to T30). 
They underwent, from T60 onwards, a zero-balance 
continuous veno-venous hemofiltration at a rate of 
45ml/kg/h. A 0.7m2 large pore (78 Å) membrane with a 
cutoff of 80kDa (Sureflux FH 70, Nipro, Osaka, Japan) and a 
hemofiltration device Baxter BM 25-BM 14 (Baxter Health 
Care, Munich, Germany) were used. Ultrafiltrate was 
replaced in the postdilution mode by a bicarbonate-buffered 
hemofiltration fluid (Na+: 150mM, K+: 3mM, bicarbonate: 
30mM) at a temperature of 37°C. 
Hemodynamic data included pulmonary artery pressure 
(PAP) wave, pulmonary blood flow wave, left atrial pressure, 
systemic arterial pressure, heart rate, RV pressure, RV 
volume and RV pressure-volume (PV) loops. These 
parameters were monitored online and recorded every 30 
minutes from T0 to T240 during a short apneic phase and 
stored for subsequent analysis. All analog signals were 
sampled at 200 Hz and continuously converted to digital form 
with an appropriate system (Codas, DataQ Instruments Inc., 
Akron, OH, USA). 
2.2 Data analysis 
A four-element windkessel model (WK4) was used to 
analyze the flow conditions in the pulmonary circulation 
throughout the experimental process. In this model (Figure 
1), a resistor (R2) represents the resistive properties of the 
pulmonary vasculature. A capacitor (C) is placed parallel to 
R2 and describes the compliant properties of the pulmonary 
arterial tree. A second resistor (R1) is placed at the input of 
the circuit and reflects the characteristic impedance of the 
proximal pulmonary stem. Finally, an inductance (L) is added 
in series to accounts for the inertial properties of the blood. 
 
Fig. 1. The four-elements windkessel model (WK4) 
 
The arterial elastance (𝐸𝑎
𝐸𝑥𝑝), which reflects RV afterload, 
was calculated from the WK4 parameters with the formula 
(Sunagawa et al., 1984): 
 
𝐸𝑎
𝐸𝑥𝑝 = (𝑅1 + 𝑅2)/[𝑇𝑠 + 𝑅2𝐶(1 − 𝑒−𝑇𝑑/𝑅2𝐶)]  (1) 
 
where Ts and Td are respectively the systolic and diastolic 
intervals, while R1, R2 and C can be estimated using a 
classical, well accepted procedure described previously 
(Lambermont et al., 1999). 
Right ventricular PV loops were obtained using the 
conductance catheter method. The RV end-systolic elastance 
(𝐸𝑒𝑠
𝐸𝑥𝑝) was determined during a rapid inferior vena cava 
occlusion maneuver (Dickstein et al., 1995). Preload was 
reduced by progressive inflation of the Fogarty balloon in the 
inferior vena cava for no more than 10s to avoid the 
intervention of a baroreflex mechanism. End-systolic PV 
relationship was determined by fitting a straight line through 
the end-systolic PV points. 
To assess the right ventricular-arterial coupling, the 𝐸𝑒𝑠
𝐸𝑥𝑝/
𝐸𝑎
𝐸𝑥𝑝  ratio was computed. Under normal operating 
conditions, the right ventricle operates at a maximum 
efficiency and a submaximal stroke work (𝐸𝑒𝑠
𝐸𝑥𝑝/(𝐸𝑎𝐸𝑥𝑝 > 1), 
while uncoupling occurs when  𝐸𝑒𝑠
𝐸𝑥𝑝/𝐸𝑎𝐸𝑥𝑝 < 1 (Fourie et al., 
1992, Lambermont et al., 2003a). 
2.4 CVS Model 
The CVS model is a lumped parameter model of 6-8 elastic 
chambers with two active chambers for the left and right 
ventricles. The original model has been extended recently 
(Desaive et al., 2008, Smith et al., 2004, Smith et al., 2006, 
 
 
     
 
Starfinger et al., 2008a, Starfinger et al., 2008d, Starfinger et 
al., 2008c) and an overview of the 8 chambers version used in 
this research is given in Figure 2. Each chamber is 
characterized by the flow in and out of the chamber, the 
pressure up- and downstream, the resistances of the heart 
valves, and inertia of the blood. 
 
 
Fig. 2. Extended CVS model overview. 
 
The CVS model uses the classical concept of time varying 
elastance proposed by Suga et al. (Suga et al., 1973) to 
simulate the cardiac muscle activation. More specifically, the 
upper and lower limits of the elastance are defined by the 
end-systolic pressure–volume relationship (ESPVR) and end-
diastolic pressure–volume relationship (EDPVR) (Burkhoff 
et al., 1988). By combining the ESPVR and EDPVR an 
equation relating the ventricular pressure (P) to the 
ventricular volume (V): 
 
𝑃 = 𝑒(𝑡)𝐸𝑒𝑠𝑟𝑣𝑓(𝑉 − 𝑉𝑑) + �1 − 𝑒(𝑡)�𝑃0(𝑒𝜆(𝑉−𝑉0) − 1) (2) 
 
where P0, V0 and λ are respectively, the pressure gradient and 
the volume at zero pressure and the curvature, while Eesrvf is 
the RV end-systolic elastance and e(t) is the activation 
function (Figure 3) that accounts for ventricular activation 
(Smith et al., 2004, Smith et al., 2006). 
 
 
Fig. 3. Plot of the activation function e(t). 
The pulmonary artery is also described by a simple pressure-
volume relationship: 
 
𝑃𝑝𝑎 = 𝐸𝑝𝑎𝑉𝑝𝑎 (3) 
 
where Ppa and Vpa denote the pulmonary artery pressure and 
volume respectively. Epa is the arterial elastance. Using 
Equations 2 and 3, the identified right-ventricular coupling 
can be computed as the ratio 𝐸𝑒𝑠𝑟𝑣𝑓/𝐸𝑝𝑎  . 
2.5  Integral-based parameter identification 
The parameter identification method used in this research has 
already been shown to rapidly and accurately identify 
virtually the entire parameter set in the presence of significant 
measurement noise (Desaive et al., 2008, Hann et al., 2006, 
Starfinger et al., 2008a, Starfinger et al., 2008d, Starfinger et 
al., 2008c) and limited measurements (Hann et al., 2009, 
Hann et al., 2010). It has been successfully tested on 
experimental animal models of pulmonary embolism 
(Starfinger et al., 2007), PEEP titrations and volume therapy 
decision support (Starfinger et al., 2008d, Starfinger et al., 
2008c), and septic shock experiments (Desaive et al., 2008, 
Starfinger et al., 2008b).  
During the identification process only the systolic and 
diastolic values of both ventricles volumes, as well as 
pressure in the aorta and in the pulmonary artery are used. It 
is important to note that in this study it was not intended to 
perfectly match the pressure and volume waveform shapes, 
but only the minimum (diastolic) and maximum (systolic) 
values. Hence, it seeks to capture the primary, clinically 
relevant dynamics for decision support at the bedside, rather 
than a potentially more perfect physiological picture. 
Furthermore, important improvements of the identification 
process have been made recently. In particular, the maximum 
and minimum volumes are no longer required, while 
maintaining the same level of identification and diagnostic 
trend accuracy reported in the prior studies cited (Hann et al., 
2009, Hann et al., 2010). 
In this model-based approach, the elastance defined in 
Equation 2 (𝐸𝑒𝑠𝑟𝑣𝑓) is directly identified from the 
experimental data using the model and the identification 
 
 
     
 
method. The arterial compliance (Cpa) and consequently the 
arterial elastance (Epa) in Equation 3 is evaluated from 
experimental data with the classical approximation (Chemla 
et al., 1998, Zhu et al., 1995) 
 
𝐸𝑝𝑎 = 1/𝐶𝑝𝑎 = 𝑃𝑃𝑎𝑆𝑉  (4) 
 
where PPa denotes the artery pulse pressure and SV the stroke 
volume.  
The arterial elastance calculated from the Windkessel model's 
parameters (𝐸𝑎
𝐸𝑥𝑝) reflects the afterload. In the model, two 
parameters may capture this effect. First Epa defined in 
equation 4. However, truer to the situation, the mean 
pulmonary inflow resistance (Rpulin) identified with the 
model-based identification process, captures this effect as 
well (Lankhaar et al., 2006, Lankhaar et al., 2008). Moreover, 
as it is identified from the data, it may better represent the 
afterload for each subject compared to the approximation in 
Equation 4. 
Hence, this study examines both a non-invasive model-based 
measure for (𝐸𝑒𝑠𝐸𝑥𝑝/𝐸𝑎𝐸𝑥𝑝  ), comparing both 𝐸𝑒𝑠𝑟𝑣𝑓/𝐸𝑝𝑎  and 
𝐸𝑒𝑠𝑟𝑣𝑓/𝑅𝑝𝑢𝑙𝑖𝑛. The goal is to obtain a non-invasive measure 
that best captures the gold-standard measure, and is also 
physiologically representative or relevant. In this case, there 
are thus two possibilities based on the physiology and how 




Figure 4 shows the mean (model-based) right ventricle end-
systolic elastance (𝐸𝑒𝑠𝑟𝑣𝑓) over all pigs during the 
experiment. This elastance is identified during the 
identification process and the value depends on the assumed 
volume at zero pressure (V0) for the ventricle used in the 
model. For reasons of simplicity, this value is assumed to be 
zero (V0 =0 ml) during the identification. However, 𝐸𝑒𝑠𝑟𝑣𝑓  
can easily be adjusted for a different and probably more 
realistic V0 as can be seen in Figure 4 where 𝐸𝑒𝑠𝑟𝑣𝑓  is 




Fig. 4. Mean identified right ventricle elastance (𝐸𝑒𝑠𝑟𝑣𝑓)  for 
all 5 analyzed pigs during the endotoxic shock experiment 
These identified 𝐸𝑒𝑠𝑟𝑣𝑓  are compared with previously 
reported values obtained for the same experimental data 
(Lambermont et al., 2006). Figure 5 shows that the values 
and the resulting correlation trends match well (R2 = 0.69) 
with a trend line defined: 𝐸𝑒𝑠𝐸𝑥𝑝 = 0.22 ∗ 𝐸𝑒𝑠𝑟𝑣𝑓 + 0.45. This 
line does not pass through the origin probably due to 
experimental errors on  𝐸𝑒𝑠𝐸𝑥𝑝 and no identification of V0 from 
the data. 
 
Fig. 5. Experimental vs simulated elastance for all 5 analyzed 
pigs during the endotoxic shock experiment. 
To compare the right ventricular-arterial coupling, we 
computed the identified coupling with  𝐸𝑒𝑠𝑟𝑣𝑓/𝐸𝑝𝑎 . Even if 
the simulated and experimental elastances match accurately, 
we found a very poor correlation for the coupling (R2 = 0.04). 
For the 𝐸𝑒𝑠𝑟𝑣𝑓/𝑅𝑝𝑢𝑙𝑖𝑛 estimate, Figure 6 shows the time 
evolution of Rpulin and 𝐸𝑎
𝐸𝑥𝑝 . Both trends match closely.  
 
Fig. 6. Rpulin and 𝐸𝑎
𝐸𝑥𝑝  for all 5 analyzed pigs during the 
endotoxic shock experiment. 
Figure 7 shows the RV-vascular coupling using 𝐸𝑒𝑠𝑟𝑣𝑓/
𝑅𝑝𝑢𝑙𝑖𝑛 during the endotoxic shock experiment as a further 
marker of the impact of sepsis. Furthermore, there is an 
improved correlation (R2 = 0.37) between the new identified 
coupling metric and the experimental coupling. 
 
4. DISCUSSION 
The major findings of this research are twofold. First, the 
results that were obtained previously (Lambermont et al., 
2006) are confirmed using the extended CVS model and 
parameter identification process. In Figure 7 it can be seen 
how hemofiltration, which starts at 60 min into the 
experiment, is able to prevent RV-vascular uncoupling (ratio 
 
 
     
 
< 1.0). This effect or behaviour is commonly observed during 
the late phases of endotoxic shock (Lambermont et al., 
2003b).  
 
Figure 7:  Mean experimental ( 𝐸𝑒𝑠𝑟𝑣𝑓/𝐸𝑝𝑎  ) and identified 
(𝐸𝑒𝑠𝑟𝑣𝑓/𝑅𝑝𝑢𝑙𝑖𝑛)  right ventricular-arterial coupling as a 
function of time for all pigs. 
In particular, the data shows that in the early phases of 
endotoxic shock, RV-vascular coupling is preserved by an 
increase in RV contractility (𝐸𝑒𝑠𝑟𝑣𝑓) as seen in Figure 4. 
During the later stages and with CVVH, RV-vascular 
coupling is preserved where a decrease in pulmonary 
vascular resistance (Rpulin), as seen in Figure 6, is suggested 
to be the main reason for this result (Lambermont et al., 
2006). These results allow for a better understanding of the 
mechanisms of RV dysfunction during septic shock and thus 
have the potential to lead to more effective therapies and 
strategies for treating myocardial depression in septic shock. 
Second, the results of this research present an important 
clinical outcome. They show that it is possible to relatively 
accurately calculate the right ventricular-arterial coupling 
without the need of an invasive preload reduction by doing 
this model-based approach. As mentioned previously, the 
assessment of RV contractility requires the occlusion of the 
vena cava which raises obvious ethical and medical concerns. 
This model-based approach uses only a clinically realistic 
and minimal data set.  
 
The RV end-systolic elastance is directly identified from the 
model and the available experimental data. Using only 
minimum and maximum values of arterial pressure and 
ventricular volume, the identification process gives an 
accurate measure of the elastance. Moreover, using the 
pulmonary resistance (Rpulin) to characterize the RV 
afterload, there is no need to evaluate the arterial elastance by 
means of the parameters of the windkessel model, which has 
the main drawback of needing accurate pressure and flow 
waveforms (Lambermont et al., 1998).  
 
Although a good correlation was found between the 
experimental and the identified measures of the preload and 
the afterload, the resulting ratio assessing ventricular-arterial 
coupling shows a comparatively poor correlation. As it is 
defined by the ratio of the preload to the afterload, there can 
be a propagation of the experimental errors. However, 
defining the RV ventricular-arterial coupling with the model-
based Rpulin value and ratio defined, 𝐸𝑒𝑠𝑟𝑣𝑓/𝑅𝑝𝑢𝑙𝑖𝑛, a good 
agreement is found with the data from (Lambermont et al., 
2006), but with a significantly smaller data set and no preload 
reduction. 
This outcome shows the importance to use patient-specific 
identified parameters instead of parameters estimated from 
the experimental data. This model-based approach thus offers 
potentially a new and more reliable procedure to assess the 
right ventricle contractility, as well as the right ventricular-
arterial coupling. It also defines a new model-based metric 
(𝐸𝑒𝑠𝑟𝑣𝑓/𝑅𝑝𝑢𝑙𝑖𝑛) that should be able, with adequate 
calibration, to monitor coupling in clinical real-time and thus 
be used in determining therapy. In particular, because every 
element of this new metric is available at the bedside and can 
be assessed effectively continuously, it is a metric that can be 
used at any point in time the clinician wishes to assess, 
diagnose, and monitor patient condition. 
 
5.  CONCLUSIONS 
This study shows the ability of the CVS model to adequately 
and realistically capture the impact of pressure-volume 
changes during endotoxic shock and with CVVH. 
Comparable results to previously reported studies are 
obtained when analyzing the RV-vascular coupling, further 
validating the here presented methods and approach. This 
research thus increases our confidence in the clinical 
applicability and validity of this overall diagnostic 
monitoring approach. 
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